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ABSTRACT 
 
 
The chemical constituents of the Malaysian Apocynaceae Kopsia singapurensis Ridl. 
(KL5334) has been carried out in this study. Seven substances ; methyl sinapate (IUPAC 
name :  (E)-methyl-3-(4-hydroxy-3,5-dimethoxyphenyl)  acrylate 82, leuconolam 83, trans-
2,2`-dicarboxyazobenzene dioxide 84, lonicerine 85, 15-hydroxykopsinine 86, singapurine 
87 and N4-hydroxymethyl kopsinic acid 88, have been isolated using several 
chromatography techniques such as column chromatography and thin layer 
chromatography from the bark of Kopsia singapurensis Ridl.. Methyl sinapate 82 and 
trans-2,2`-dicarboxyazobenzene dioxide 84 are new natural compounds while singapurine 
87 and N4-hydroxymethyl kopsinic acid 88 are two new indole alkaloids. The structures of 
the isolated compounds were elucidated by using spectroscopic techniques namely NMR 
(
1
H, 
13
C and 2D), UV, IR and mass spectrometry. 
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ABSTRAK 
 
 
Kandungan kimia yang terdapat dalam Malaysia Apocynaceae Kopsia singapurensis Ridl. 
(KL5334) telah dikaji dalam penyelidikan ini. Tujuh sebatian; metil sinapat (nama IUPAC ; 
(E)-metil-3-(4-hidroksi-3,5-dimetoksifenil) akrilat 82, leukonolam 83, trans-2,2`-
dikarboksiazobenzen dioksida 84, loniserina 85, 15-hidroksikopsinina 86, singapurina 87 
dan N4-hidroksimetil asid kopsinik 88 telah diasingkan menerusi beberapa kaedah 
kromatografi seperti kromatografi turus dan kromatografi lapisan nipis daripada kulit 
batang Kopsia singapurensis Ridl. Metil sinapat 82 dan trans-2,2`-dikarboksiazobenzen 
dioksida 84 adalah sebatian semulajadi yang baru manakala singapurina 87 dan N4-
hidroksimetil asid kopsinik 88 adalah dua alkaloid indola baru. Penentuan struktur kimia 
telah dibuat mengunakan teknik spektroskopi iaitu NMR (
1
H, 
13
C dan 2D), UV, IR dan 
spektrometri jisim. 
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  INTRODUCTION 
 
1.1 General 
 
For thousands of years, natural products have played an important role throughout the 
world in treating and preventing human diseases.
1
 Just over 200 years ago, a 21 year old 
pharmacist`s apprentice named Friedrich Serturner isolated the first pharmacologically 
active pure compound from a plant: morphine from opium produced by a cut seed pods of 
the poppy, Papaver somniferum.
2
 By 1990, about 80% of drugs were either natural 
products or analogs inspired by Second World War.
3
  
 
Antibiotics (e.g., penicillin, tetracycline, erythromycin), antiparasitics (e.g., avermectin), 
antimalarials (e.g., quinine, artemisinin), lipid control agents (e.g., lovastatin and analogs), 
immunosuppressants for organ transplants (e.g., cyclosporine, rapamycins) and anticancer 
drugs (e.g., taxol, doxorubicin) revolutionized medicine.
3
 
 
Today even with the advent of new technologies, the majority of new drugs is still 
generated from natural products (secondary metabolites) or from compounds derived from 
natural products.
3
 An analysis of the origin of the drugs developed between 1981 and 2002 
showed that natural products or natural product, derived drugs comprised 28% of all new 
chemical entities (NCEs) launched onto the market.
4
 In addition, 24% of these NCEs were 
synthetic or natural mimic compounds related to natural products.
5
 This combined 
percentage (52% of all NCEs) suggests that natural products are important sources for new 
2 
 
drugs and are also good lead compounds suitable for further modification during drug 
development.
1
 
 
Besides, within  2000 to 2005, over 20 new drugs were launched on the market.
1
 In fact, a 
recent analysis by Newman
6
 et al. and Butler
7
 et al., from 1981 to 2007 indicate that almost 
half of the drugs approved since 1994 are based on natural products. Thirteen natural 
product-derived drugs were approved in the United States between 2005 and 2007, with 
five of them being the first members of a new class.
7,8
  
 
Most of the leads from natural products that are currently in development have come from 
either plant or microbial source.
8
 Malaysia is known for its diverse variety of flora and 
fauna that have been around for millions of years. The flora is regarded as one of the richest 
and oldest in the world. This may be attributed to the climate in Malaysia which is 
constantly warm and nearly uniform, suitable for the growth of tropical rainforests. Hence 
it is an interesting site to search for medicinal plants and potential drugs or lead 
compounds. In addition, natural resources from tropical rain forest are a promising source 
of biologically active compounds.
9
 The importance of the region`s diverse medicinal plants 
lies not only in their chemotherapeutic value in traditional health care but also in their 
potential as source of NCEs for drug discovery.
10
 
 
In Malaysia, efforts in discovering new potential antiplasmodial drugs is still of great 
interest since, most malaria cases in this country are caused by Plasmodium falciparum.
9
 
Present drug have become ineffective because of the occurrence of resistance P. 
falciparum, particularly to chloroquine.
9
 By 1963, chloroquine resistant has been reported  
3 
 
in Malaysia.
11
 Currently, the only fully effective class of antimalarial drug is the 
artemisinin.
12
 Artemisinin from Artemesia annua is a sesquiterpenoid that is effective 
against multi-drug-resistant Plasmodium species but is expensive for Third World patients.
3
 
In all malaria endemic countries, plants are used in traditional medicine for treatment of the 
diseases.
13
  
 
In view of the fact that Malaysia has many plants of medicinal importance the author has 
embarked of Kopsia singapurensis Ridl an investigation or its chemical constituents and 
potential antiplasmodial activities. The objectives of this study are: 
 
 To extract and isolate the compounds from K. singapurensis Ridl. using 
chromatographic methods. 
 To elucidate the structure of the compounds using modern spectroscopic methods 
such as 
1
H-NMR, 
13
C-NMR, COSY, DEPT, HMBC, HMQC, IR, MS and UV. 
 To determine antiplasmodial activity against the extract and the isolated compounds 
from K. singapurensis.   
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1.2 Apocynaceae 
 
Apocynaceae is a family of flowering plants, including trees, shrubs and herbs. The family 
was currently recognized, comprising 1500 species classified in about 424 genera.
14
 
However in Malaysia nearly 120 species which are classified into 32 genera of this family 
are distributed over lowlands and mountains.
15
  
 
1.3 Genus Kopsia 
 
Genus Kopsia belongs to Rauvolfieae tribe, subfamily Plumerioidiae of the Apocynaceae 
family
16,17,18
(Scheme 1.1). By contrast, Sevenet et. al
19
 has reported that this genus belongs 
to the subtribe Vallesiinae, close to Ochrosiinae in Plumerioideae-Rauvolfioideae 
subfamily.  
 
The genus Kopsia (Apocynaceae) comprises of 30 species which are native to China, India 
and southeast
20-25
 and about 18 species are to be found in Malaysia. This genus was 
identified to generate a great number of biologically active indole alkaloids possessing 
interesting skeletons 
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Apocynaceae 
Plumerioideae 
Carisseae Tabernaemontaneae Plumerieae Rauvolfieae 
Carpodinus 
Hunteria 
Landolphia 
Melodinus 
Picralima 
Pleiocarpa 
Polyadoa 
Anacampta Pagiantha 
Bonafousia Pandaca 
Callichilia Peschiera 
Capuronetta Phrissocarpus 
Conopharyngia Rejoua 
Crioceras Schizozygia 
Ervatamia Stemmadenia 
Gabunia Stenosolen 
Hazunta Tabernaemontana 
Hedranthera Tabernanthe 
Muntafara Voacanga 
Alstonia Gonioma 
Ammocallis Haplophyton 
Amsonia Lochnera 
Aspidosperma Plumeria 
Catharanthus Rhazya 
Craspidospermum Tonduzia 
Diplorhynchus Vinca 
Geissospermum 
Bleekeria 
Cabucala 
Excavatia 
Kopsia 
Neisosperma 
Ochrosia 
Rauvolfia 
Vallesia 
Subfamily 
Tribes 
 
 
 
  
 
Scheme 1.1: Classification of Apocynaceae Family 
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1.4 Kopsia singapurensis Ridl. 
 
K. singapurensis Ridl. (White Kopsia)
26
 or locally known as “selada” is a small 
evergreen tree with a conical crown, up to 25 feet high. In Malaya, this plant was 
distributed from Negeri Sembilan southward to Singapore and common in lowland marshy 
forest. The leaves are elliptic, thin with a distinct blunt tip up to 0.5 in long and 4.0 in wide, 
rather dark green. The bark is grayish buff to pale silvery brownish. The flowers are rather 
loose clusters on stalks 1.5 - 3.0 in long and 1.0 - 1.5 in or 2.0 - 3.0 in wide. The fruit is   
1.5 in long and 0.75 in wide, flattened, triangular in outline, finely hairy but glabrous
26
 
(Figure 1.1). 
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Figure 1.1: Various part of K.singapurensis 
The flower of K. singapurensis The leaf of K. singapurensis 
The bark of K. singapurensis 
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1.5 Alkaloids Isolated from Kopsia singapurensis 
Previous investigation on K. singapurensis afforded many skeletal types of indoles such as 
aspidofractinine, mersinine, aspidosperma, vincorine and akuammiline.
25,27-35,18,36
 Table 
1.5.1 showed the list of different compounds isolated from Kopsia singapurensis Ridl.. 
 
Table 1.1: List the alkaloids isolated from Kopsia singapurensis Ridl.. 
 
 
Skeletal type 
 
Name 
 
 
References 
 
Class* 
 
i) Aspidofractinine  
 
Kopsiloscine A 1 
Kopsiloscine B 2 
Kopsiloscine C 3 
Kopsiloscine D 4 
Kopsiloscine E 5 
Kopsiloscine F 6 
Kopsiloscine G 7 
Kopsiloscine H 8 
Kopsiloscine I 9 
Kopsiloscine J 10 
(17α)-17-hydroxy-∆14-kopsinine 11 
Kopsidarine 12 
Kopsinitarine A 13 
Kopsinitarine B 14 
Mersingine A 15 
Singapurensine A 16 
Singapurensine B 17 
Singapurensine C 18 
Singapurensine D 19 
Kopsimaline A 20 
Kopsimaline B 21 
Kopsimaline C 22   
Kopsimaline D 23 
Kopsimaline E 24 
Kopsimaline F 25 
Kopsidine A 26 
Kopsidine C 27 
Kopsidine D 28 
Kopsidine C N-oxide 29 
Kopsinicine 30 
Kopsofinone 31 
 
31 
31 
31 
31 
31 
31 
32, 57 
32 
32 
32 
31, 32, 57 
57 
57 
57 
57 
34 
34 
34 
34 
32 
32 
32 
32 
32 
57 
57 
57 
31 
57 
32 
32 
 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
 9 
 
Kopsinine 32 
N-decarbomethoxykopsamine 33 
Kopsilongine-N-oxide 34 
16-epikopsinine 35     
Kopsilongine 36 
Kopsaporine 37 
Kopsingine 38 
Kopsinganol 39 
11,12-methylenedioxykopsaporine 40 
15-hydroxykopsinine-N-oxide 41 
Singaporentine A 42 
Kopsingarine 43 
Kopsifoline A 44 
Kopsinic acid 45 
 
31, 32, 57 
32 
31 
31 
31 
31, 35 
31, 35, 57 
31, 57 
34 
18 
56 
35 
56 
56 
 
 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
 
 
ii)    Mersinine 
 
Mersirachine 46 
Mersinaline 47 
Mersinine A 48   
Mersinine B 49 
Mersinine C 50 
Mersifoline A 51 
Mersifoline B 52 
Mersifoline C 53 
Mersiloscine 54 
Mersiloscine A 55 
Mersiloscine B 56 
Mersidasine A 57 
Mersidasine B 58 
Mersidasine C 59   
Mersidasine D 60   
Mersidasine E 61   
Mersidasine F 62 
Mersidasine G 63 
 
 
32, 33 
32, 33 
25 
25 
25 
25 
25 
25 
25 
25 
25 
25 
25 
25 
25 
25 
25 
25 
 
 
              
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
      
 
iii)   Aspidosperma 
 
Rhazinilam 64 
Rhazinal 65 
Rhazinicine 66   
5,21-Dihydrorhazinilam 67 
Leuconolam 68 
Leuconoxine 69    
 
 
31, 32, 57 
31 
31 
32, 57 
31, 32 
32 
 
 
II 
II 
II 
II 
 II 
II 
 
iv)   Condylocarpine  
 
14α-hydroxycondylocarpine 70 
 
 
32 
 
I 
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v)   Vincorine 
 
Vincophylline 71 
 
31 
 
I 
 
vi)   Aspidodasycarpine 
 
Aspidodasycarpine 72 
Lonicerine 73    
Aspidophylline A 74 
Aspidophylline B 75 
 
 
31, 32, 57 
31, 32, 57 
31 
57 
 
I 
I 
I 
I 
 
vii)   Akuammiline 
 
Akuammidine 76 
Deacetylakuammiline 77 
16-epiakuammiline 78 
16-epideacetylakuammiline 79 
 
 
31, 32, 57 
32 
31, 32, 57 
31, 32, 57 
 
I 
I 
I 
 
 
viii) Yohimbine 
 
Tetrahydroalstonine 80 
 
31, 32 
 
I 
 
ix)   Pleoicarpamine 
 
16-hydroxymethylpleiocarpamine 81 
 
32 
 
I 
 
* Please refer to Scheme 2.1 and Section 2.2 
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i) Aspidofractinine type 
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Continued…. 
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Continued…. 
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Continued…. 
 
 
 
 
 
 
 
 
 15 
 
ii) Mersinine type 
 
 
 16 
 
Continued….. 
 
 
 
 17 
 
iii) Aspidosperma type 
 
 
 
iv) Condylocarpine type 
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v) Vincorine type 
 
 
 
vi) Aspidodasycarpine type 
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vii) Akuammiline type 
 
 
 
viii) Yohimbine type 
 
 
 
ix) Pleoicarpamine type 
 
 
 20 
 
 
GENERAL ASPECTS OF INDOLE ALKALOIDS 
 
2.1 General  
 
Indole alkaloids have been the subject of many chemical and biosynthetic studies due to 
their complex and diversed chemical structures and also their interesting biological 
activities. In the following sections, the author shall discuss the classification and 
biosynthesis of indole alkaloids.  
 
2.2 Classification of Indole Alkaloids 
 
All indole alkaloids can be classified into five main classes from the structure of the carbon 
skeleton of the non-tryptamine unit.
37
 Class I to Class III is derived from secologanin while 
Class IV is not derived from secologanin and Class V consists of binary indole alkaloids. 
(See Scheme 2.1: The three major skeletal classes from loganin). After condensation with 
tryptophan 94, these skeletal systems can be determined in an unrearranged form as α- or β- 
condensation products. (Refer to 2.3: Biosynthesis of Indole Alkaloids). 
 
 
 
 
 
 
 21 
 
 
 
 
Scheme 2.1: The three major skeletal classes from loganin 
 
2.3 Biosynthesis of Indole Alkaloids 
 
The indole group is highly structurally varied. Simple tryptamines such as  psilocybin 89 
the hallucinogenic principle of the Mexican ceremonial mushroom, are found in nature.
38
 
The indole ring is mechanistically available for alkylation’s or oxidation both at α- and β- 
 22 
 
positions; β-methylation (and spontaneous cyclization of the amine) of a tryptamine 90 can 
thus lead to physostigmine 91, an African ordeal poison; β - oxidative coupling yields the 
Calycanthaceae group; folicanthine 92. The Mannich condensation (with an equivalent of 
CH3CHO) proceeds at α-position to furnish -carboline group; harmine 93.
38
 
 
More complex indole alkaloids are generally derived from  tryptamine  90 by Mannich 
condensation either at the indolic α- and β- positions.38 According to Battersby39,40 et al. 
and Blackstock
41,40
 et al., condensation of  tryptamine 90 (or  tryptophan 94) with  
secologanin 95, a monoterpene glucoside, to give rise to a nitrogeneous glucoside, 
vincoside 96. Many of these indole alkaloids contain the skeletal fragment biogenetically 
symbolized in 97.
38
 They are shown in heavy lines in some of the examples but in some 
molecules, particularly those from Tabernanthe species; voacangine  98 and Hunteria 
species; eburnamonine  99 and the  aspidospermine  100 are rearranged. The circled carbon 
in 97, as in   yohimbine  101 may have its origin in an oxidized N-methyl.
38
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The Mannich condensation of the aldehydic secologanin complex with the indole 97 
resulted in two groups.  Cyclization involving the α-position usually leads to true indoles, 
as in  yohimbine 101, corynantheine 102,  cinchonamine 103 and  ajmaline 104; whereas β-
condensation must block indolic unsaturation with a quartenary center as in  mitraphylline  
105 and caracurine VII 106. A number of other alkaloids are biogenetically derived from 
these by a few further transformations, as in the conversion of cinchonamine (or a close 
relative) to the quinine 107 family skeleton via opening of the indole ring and enclosure of 
the aniline nitrogen on the side chain. Indeed Leete finds radioactive tryptophan 94 a 
precursor of this group. Interesting if somewhat more involved schemes may be constructed 
to afford  stemmadenine 108, ellipticine  109 and  gelsemine  110 from a starting point of 
the   caracurine type 106.
38
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The hallucinogens from the rye fungus (ergot), thought to have been the cause of St. 
Vitus`s Dance in medieval times, are peptide amides of the interesting  lysergic acid 111, to 
be a biosynthetic product of   tryptamine  90 and  mevalonic acid 112. The most complex 
bases are the dimeric indole alkaloids such as the many constituents of calabash curare, 
 27 
 
derived from caracurine by a simple dehydrative dimerization and exemplified in the 
common  toxiferine  113 and  voacamine  114 and the very similar vinblastine 115, an 
anticancer agent isolated from the humble periwinkle.  
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Table 2.1: Biogenetic Classification of Indole Alkaloids
42,43,36
 
 
Class I 
     
Vallesiachotamine group 
 
 
Picraline group 
 
 
Condylocarpine group 
 
 
Corynine group 
 
Strychnine group 
 
Ajmaline group 
 
Adifoline group 
 
Perakine group 
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Talbotine group 
 
 
 
 
Vincoside group 
 
 
 
 
Stemmadenine group 
 
 
 
Corynantheine group 
 
 
 
Mavacurine group 
 
 
 
Sarpagine group 
 
 
Cinchonamine group 
 
 
Peraksine group 
 
 
 
 30 
 
Secodine group       
              
Cadambine group 
 
Aspidodasycarpine group 
 
 
Ajmalicine group 
 
 
Class II 
                                            
Aspidospermine group 
 
 
 
Pleiocarpine group 
 
 
Kopsine group 
 
 
Vindoline group 
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Fruticosine group 
 
Schizophylline group 
  
Schizozygine group 
 
            Vincamine group 
 
Class III 
 
Catharanthine group 
 
 
 
Andranginine group 
 
 
             Pandoline group 
 
 
 
Nitramidine group  
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  Class IV  (not derived from secologanin) 
i) Non-tryptophan indole alkaloids (carbazole alkaloids) 
Murrayanine group 
 
Currayangine group 
 
ii) Non-isoprenoid tryptophan alkaloids 
Tryptophan group 
 
Harmaline group 
 
iii) Isoprenoid tryptophan alkaloids (fungal indole alkaloid) 
Isopentenyl tryptophan group 
 
Clavicipitic acid group 
          
Class V (binary indole alkaloids) 
II-III group 
 
I-IV group 
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RESULTS AND DISCUSSION 
 
3.0 Introduction 
 
The present work deals with the isolation and structural elucidation of alkaloids 
from Kopsia singapurensis (bark). Seven compounds were isolated and characterized; 
methyl sinapate (IUPAC name ; (E)-methyl-3-(4-hydroxy-3, 5-dimethoxyphenyl) acrylate 
82, leuconolam 83, trans-2,2`-dicarboxyazobenzene dioxide 84, lonicerine 85, 15-
hydroxykopsinine 86, singapurine 87 and N4-hydroxymethyl kopsinic acid 88 (Table 3.0). 
 
Various chromatographic techniques such as column chromatography and TLC 
have been used to isolate the compounds. The structures were determined by a combination 
of spectroscopic methods; 1D-NMR (
1
H, 
13
C, DEPT), 2D-NMR (COSY, NOESY, 
HMQC/HSQC and HMBC), UV, IR, MS (GCMS, LCMS and HRMS). The structures of 
the compounds were also elucidated by comparison with the previous work. The following 
subchapters/paragraphs will discuss on structural elucidation of all compounds isolated. 
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Table 3.0: Compounds isolated from Kopsia singapurensis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMPOUND Yield (g) 
COMPOUND A ; 
methyl sinapate (IUPAC name : 
(E)-methyl-3-(4-hydroxy-3,5-dimethoxyphenyl) acrylate 82 
0.0022 
COMPOUND B ; 
leuconolam 83 
0.0020 
COMPOUND C ;  
trans-2,2`-dicarboxyazobenzene dioxide 84 
0.0040 
COMPOUND D ;  
lonicerine 85 
0.0065 
COMPOUND E ; 
15-hydroxykopsinine 86 
0.0183 
COMPOUND F ;  
singapurine 87 
0.0044 
COMPOUND G ;  
N4-hydroxymethyl kopsinic acid 88 
0.0073 
 35 
 
3.1 COMPOUND A; Methyl sinapate 82 
 
 
 
 
 
 
 
 
 
 
Compound A was obtained as yellowish amorphous. The HREIMS exhibited a 
pseudo molecular ion peak at m/z 239.0732 [M+H]
+
, suggesting a molecular formula of 
C12H14O5. Absorptions at 3398, 1706 and 1113 cm
-1
 in IR spectrum indicated the presence 
of hydroxyl (OH), carbonyl (C=O) and (C-O) groups respectively
44
.  
 
The 
1
H-NMR spectrums showed a singlet corresponding to two aromatic protons at 
δ 6.77 which may be attributable to H-2 and H-6 respectively. Methoxyls attached to C-3 
and C-5 resonated as a singlet at δ 3.92. Another singlet corresponding to the methoxyl 
attached to C-1` was also observed at δ 3.80. H-2` and H-3` resonated as a pair of doublet 
(J = 16 Hz) at δ 6.30 and δ 7.60 respectively. The presence of these two protons was further 
confirmed by using 
1
H-
1
H COSY spectrum. 
 
The 
13
C-NMR (Figure 3.2), DEPT (Figure 3.3) spectrum of compound A further 
confirmed the presence of twelve carbons. The DEPT spectrum showed four methines;       
δ 105.4 (C-2 and C-6), 115.9 (C-2`) and 145.5 (C-3`) and four quartenary carbon signals at 
δ 126.5 (C-1), 147.6 (C-3 and C-5) and 167.8 (C-1`) respectively (Table 3.1). The HMBC 
spectrum (Figure 3.5) showed the correlations between H-2 with C-6, C-1, C-4 and C-3`, 
whereas H-6 showed crosspeaks with C-2, C-1, C-4 and C-3`. The NOE-diff experiment 
 36 
 
showed enhancement of H-2 and H-6 upon irradiation of the methoxyl protons of C-3 and 
C-5 indicating that C-4 is substituted by an OH group.  
 
Based on the spectral data observed from DEPT, HSQC, HMBC, NOE-diff and 
comparison with literature compound A is indeed the known methyl sinapate
45,46
 [IUPAC 
name; (E)-methyl-3-(4-hydroxy-3,5-dimethoxyphenyl) acrylate]. This is the first report on 
the occurrence of methyl sinapate A in nature. 
 
Table 3.1:  
1H NMR [400 MHz, δH (J, Hz)] and 
13
C NMR [100 MHz, δC] of compound A 
      in CDCl3 
 
Position                                           
1
H (J, Hz)                          
13
C                          
1         126.5 
2     6.77 (s)   105.4 
3         147.6 
4-OH     5.76 (s)   137.5 
5         147.6 
6     6.77 (s)   105.4 
1`         167.8 
2`     6.30 (d, 16.0 Hz)  115.9 
3`     7.60 (d, 16.0 Hz)  145.5 
1`-OCH3    3.80 (s)     52.1 
3-OCH3    3.92 (s)     56.7 
5-OCH3    3.92 (s)     56.7  
 
 
 
 
 
 
 
37 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: 
1
H-NMR Spectrum of Compound A 
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Figure 3.2: 
13
C-NMR Spectrum of Compound A 
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Figure 3.3: DEPT Spectrum of Compound A 
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Figure 3.4: HSQC Spectrum of Compound A 
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Figure 3.5: HMBC Spectrum of Compound A 
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3.2 COMPOUND B; leuconolam 83 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound B, was isolated as a yellowish amorphous. The HREIMS showed the pseudo-
molecular ion peak at m/z 325.1461 [M-H]
+
 which matched with the molecular formula 
C19H22N2O3. The IR spectrum  revealed absorption at 1689 cm
-1  
indicating the presence of 
a lactam carbonyl group.
44,47
  
 
The 
1
H-NMR spectrum (Figure 3.6) revealed a number of important features, including the 
presence of ethyl group which was evidenced by the appearance of a CH2-19 multiplet at δ 
1.45 and 1.35 and a triplet of CH3-18 at δ 0.77. The four aromatic proton signals appeared 
at δ 7.45 (dd, J = 7.5, 1.1Hz), δ 7.12 (dt, J = 7.5, 1.1 Hz), δ 7.33 (dt, J = 8.2, 1.1 Hz) and δ 
8.15 (d, 8.2 Hz). Two sets of ddd corresponding to H-3a and H-3b were observed at δ 3.22 
and δ 4.46. They are deshielded since they are adjacent to the nitrogen (N2), an 
electronegative atom. Other methylene proton (H-14, H-15, H-16, H-17) signals were 
apparent between δ 1.13 to δ 3.09. 
 
The 
13
C-NMR (Figure 3.7) and DEPT spectrum of compound B showed nineteen carbon 
signals corresponding to nineteen carbon atoms; five methines at δ 116.2 (C-12), 118.4 (C-
FIGURE 6 HMBC SPECTRUM OF COMPOUND A 
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6), 121.8 (C-9), 124.6 (C-10) and 131.8 (C-11), six methylenes at δ 17.0 (C-14),             
26.3 (C-15), 30.7 (C-17), 33.4 (C-16), 34.4 (C-19) and 37.2 (C-3), one methyl signal at δ 
8.5 (C-18) and seven quaternary carbons in which two are carbonyl carbons (C-2, δ 173.7) 
and (C-5, δ 176.4) in agreement with the presence a broad and strong IR absorption at 1689 
cm
-1
.
44,47
 
 
In addition, other quaternary carbon resonances were observed at δ 164.5 (C-7), δ 123.8  
(C-8), δ 148.8 (C-13) and δ 48.8 (C-20). The observed three-bond correlation from H-6 to 
C-21 in the HMBC (Figure 3.10) spectrum not only confirmed the assignment of H-6 but 
also defined the location of the five membered ring lactam groups. The complete 
assignments of 
1
H and 
13
C were aided by the HMBC, HSQC and COSY experiments and 
were listed in Table 3.2. 
 
In conclusion, comparison with the literature values confirmed that compound B is 
leuconolam.
48-50,47
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Table 3.2: 
1H NMR [400 MHz, δH (J, Hz)] and 
13
C NMR [100 MHz, δC] of compound B 
     in CDCl3 
Position                                   
1
H (J, Hz)                             
13
C                          
2         173.7 
3    3.22 (ddd, 15.5, 9.6, 6.4 Hz)    37.2    
    4.46 (ddd, 15.5, 11.8, 2.9 Hz)     
4     
5         176.4 
6    6.19 (s)    118.4   
7         164.5 
8         123.8  
9    7.45 (dd, 7.5, 1.1Hz)   121.8    
10    7.12 (dt, 7.5, 1.1 Hz)   124.6   
11    7.33 (dt, 8.2. 1.1 Hz)   131.8    
12    8.15 (br d, 8.2 Hz)   116.2   
13         148.8    
14    1.77 (m)      17.0   
    2.03 (m) 
15    1.13 (m)      26.3   
    1.64 (m) 
16    2.65 (ddd, 16.0, 5.0, 1.8 Hz)    33.4   
    3.09 (dt, 16.0, 5.9 Hz)      
17    1.67 (m)      30.7   
    2.09 (m)     
18    0.77 (t, 7.3 Hz)       8.5    
19    1.35 (m)      34.4 
    1.45 (m)    
20           44.8    
21-OH           93.6   
NH    3.64 (br s) 
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FIGURE 6 HMBC SPECTRUM OF COMPOUND A 
Figure 3.6: 
1
H-NMR Spectrum of Compound B 
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Figure 3.7: 
13
C-NMR Spectrum of Compound B 
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Figure 3.8: COSY Spectrum of Compound B 
H-12, H-11 
NoEdiff 
H-9, H-10 
NoEdiff 
H-11, H-10 
NoEdiff 
H-3, H-3’ 
H-16, H-16’ 
H-16, H-17’ 
H-19, H-18 
H-15, H-15` 
H-17, H-17’ 
 48 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9: HSQC Spectrum of Compound B 
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Figure 3.10: HMBC Spectrum of Compound B 
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3.3 COMPOUND C; trans-2, 2`- dicarboxyazobenzene dioxide 84 
 
 
 
 
 
 
 
 
 
 
 
Compound C was obtained as greenish amorphous solid. The mass spectrum of this 
alkaloid revealed a pseudo-molecular ion peak at m/z 325.1311 [M+Na]
+
 which 
corresponded to the molecular formula C14H10N2O6. The IR spectrum showed a broad band 
at 3350 cm
-1
 and 1623 cm
-1
 – 1653 cm-1 indicating the presence of a conjugated carboxylic 
acid moiety and nitroso group respectively.
44
 In addition, the trans nature of the dimer 
aromatic nitroso compounds is implied from the IR absorption at 1254 cm
-1
.
51
 
 
The 
1
H-NMR spectrum (Figure 3.11) and (Table 3.3) showed a singlet at  12.14 which 
may be attributed to the proton of COOH. The four aromatic protons appeared at  7.01 
(dd, 8.3, 0.9 Hz, H-3),  7.45 (ddd, 8.3, 7.3, 1.5 Hz, H-4),  6.87(ddd, 8.0, 7.3, 0.9 Hz, H-5) 
and  7.38 (dd, 8.0, 1.5 Hz, H-6). 
 
The 
13
C-NMR (Figure 3.12) spectrum of compound C indicated the presence of seven 
carbons. However, the real carbon number is fourteen as this compound is a dimer. Both 
parts of the compound are linked by the nitroso group. 
Figure 3.1.2.4: COSY Spectrum of Compound 2 
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The DEPT spectrum gave signals of four methines at  119.1 (C-3 and C-5), 135.4 (C-4), 
126.8 (C-6). The complete assignments of 
1
H and 
13
C were assisted by COSY, HSQC and 
HMBC experiments and were listed in Table 3.3. Thorough examination of the spectral 
data led to the identification of compound C as trans-2, 2`-dicarboxyazobenzene dioxide.
51
 
This is the first report of its occurrence in nature. 
 
Table 3.3: 
1
H NMR [400 MHz, δH (J, Hz)] and 
13
C NMR [100 MHz, δC] of compound C 
      in CDCl3 
 
Position                                   
1
H (J, Hz)                             
13
C                          
1         113.5 
2         162.5 
3    7.01 (dd, 8.3, 0.9 Hz)   119.1 
4    7.45 (ddd, 8.3, 7.3, 1.5 Hz)  135.4 
5    6.87 (ddd, 8.0, 7.3, 0.9 Hz)  119.1 
6    7.38 (dd, 8.0, 1.5 Hz)   126.8 
1`         113.5 
2`         162.5 
3`    7.01 (dd, 8.3, 0.9 Hz)   119.1 
4`    7.45 (ddd, 8.3, 7.3, 1.5 Hz)  135.4 
5`    6.87 (ddd, 8.0, 7.3, 0.9 Hz)  119.1 
6`    7.38 (dd, 8.0, 1.5 Hz)   126.8 
1
COOH   12.14 (s)    172.0 
2
COOH   12.14 (s)    172.0
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Figure 3.11: 
1
H-NMR Spectrum of Compound C 
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Figure 3.12: 
13
C-NMR Spectrum of Compound C 
 
 54 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: HSQC Spectrum of Compound C 
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Figure 3.14: HMBC Spectrum of Compound C 
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3.4 COMPOUND D; lonicerine 85 
 
 
 
 
 
 
 
 
 
 
 
Compound D – lonicerine was obtained as yellowish oil. The mass spectrum of this 
alkaloid revealed a pseudo-molecular ion peak at m/z 371.1706 [M+H]
+
 which 
corresponded to the molecular formula of C21H26N2O4. The IR spectrum showed a broad 
band at 3320 cm
-1
 indicating the presence of hydroxyl group. The UV spectrum showed 
absorptions characteristic of an unsubstituted dihydroindole chromophore; 204, 245 and 
294 nm.
52
 
 
The 
1
H-NMR spectrum (Figure 3.15) showed the presence of signals for four aromatic 
protons at δ 7.07 (d, J = 7.8 Hz, H-9), δ 6.68 (t, J = 7.8 Hz, H-10), δ 6.99 (t, J = 7.8 Hz, H-
11) and δ 6.53 (d, J = 7.8 Hz, H-12). The 1H-NMR also showed the existence of an 
ethylidene group (δ 1.59, d, J = 6.6 Hz, H3-18; δ 5.85, q, J = 6.6 Hz, H-19), one methoxyl 
at δ 3.05 (s, 22-OCH3). The unusual shielded chemical shift value of the methoxyl may be 
due to the anisotropic effect  since the methoxyl protons were oriented on top of the 
FIGURE 7: IR SPECTRUM OF COMPOUND A 
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benzene
53
, a high electron density area. In addition, two doublets appeared at δ 3.23 and     
δ 3.59 or a coupling constant value of 13.9 Hz which can be assigned to the methylene 
protons of C-21. A pair of an AB doublet corresponding to H-17 was observed at δ 3.77 -    
δ 3.85. 
 
The 
13
C-NMR spectrum (Figure 3.16) showed 21 signals corresponding to the 21 carbons; 
seven methines at δ 53.2 (C-3), 124.5(C-9), 119.0 (C-10), 128.2(C-11), 107.5 (C-12), 33.5 
(C-15) and 122.1 (C-19), five methylenes at δ 66.7 (C-5), 37.5 (C-6), 28.2 (C-14), 65.3 (C-
17) and 48.7 (C-21), one methyl at δ 13.1 (C-18) and one methoxy signal at δ 51.6 (C-22 
OCH3). In addition there are seven quartenary carbon in which one is a carbonyl of an ester 
at δ 176.9 (C-22) (Table 3.4).       
 
Thorough analysis of the COSY, HSQC and HMBC spectra allowed the complete 
assignment of all signals (Table 3.4). In conclusion, comparison with the literature values 
confirmed that compound D is lonicerine.
53,18
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Table 3.4: 
1
H NMR [400 MHz, δH (J, Hz)] and 
13
C NMR [100 MHz, δC] of lonicerine D 
     in CDCl3 
 
Position  
1
H (J, Hz)    
13
C                           
2        102.5 
3   3.23 (m)      53.2 
4 
5   4.03 (br t, 7.5 Hz)     66.7 
   3.41 (m) 
6   2.88 (m)      37.5 
   2.52 (dd, 12.8, 4.6 Hz) 
7          55.3 
8        134.4 
9   7.07 (d, 7.8 Hz)   124.5 
10   6.68 (t, 7.8 Hz)   119.0 
11   6.99 (t, 7.8 Hz)   128.2 
12   6.53 (d, 7.8 Hz)   107.5 
13        148.6 
14   2.79 (m)      28.2 
   1.75 (m) 
15   2.83 (m)      33.5 
16          57.5 
17   3.77 (br d, 12.1 Hz)     65.3 
   3.85 (br d, 12.1 Hz) 
18   1.59 (d, 6.6 Hz)     13.1 
19   5.85 (q, 6.6 Hz)   122.1 
20        133.6 
21   3.23 (d, 13.9 Hz)     48.7 
   3.59 (d, 13.9 Hz) 
22        176.9 
22-OCH3  3.05 (s)      51.6 
NH   4.26 (s) 
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Figure 3.15: 
1
H-NMR Spectrum of compound D 
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Figure 3.16: 
13
C-NMR Spectrum of compound D 
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Figure 3.17: COSY Spectrum of compound D 
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Figure 3.18: HSQC Spectrum of compound D 
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Figure 3.19: HMBC Spectrum of compound D 
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3.5 COMPOUND E ; 15-hydroxykopsinine 86 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound E, was isolated as a brownish amorphous solid. It`s mass spectrum showed a 
pseudo-molecular ion peak at m/z 355.1760 [M+H]
+
 which corresponded to the molecular 
formula of C21H26N2O3 as indicated by its mass spectrum. The IR spectrum exhibit 
absorption at 3336 cm
-1
 and 1724 cm
-1
 indicating the presence of a hydroxyl group and a 
carbonyl ester group respectively. The UV spectrum showed absorptions characteristic of 
dihydroindole chromophore.
52
 
 
The 
1
H-NMR spectrum (Figure 3.20) showed four aromatic proton signals at δ 7.23 (m), δ 
6.74 (t, 7.3Hz), δ 6.97 (t, 7.7 Hz) and δ 6.63 (d, 7.7 Hz) which can be attributed to H-9, H-
10, H-11 and H-12 respectively. The 
1
H and 
13
C NMR spectra of this compound were 
nearly identical of venalstonine
54,55
 except for the absence of the two olefinic proton signals 
at C-14 and C-15. Instead a downfield proton signal at δ 3.65 was observed which is 
assignable to H-15 which is in proximity with a hydroxyl group. The methoxyl protons at 
C-22 resonated as a singlet at δ 3.75. H-21 which is close to N4 resonated at δ 3.66. Other 
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aliphatic protons CH2, H2-5 and H2-3 whose carbons are attached to N4 resonated at            
δ 3.06 / δ 3.35 and δ 2.90 / δ 3.45 respectively. Other proton signals (H2-6, H2-14, H-16, 
H2-17, H2-18, H2-19) appeared in the upfield region between δ 1.24 to δ 2.89 (Table 3.5). 
 
The 
13
C-NMR spectrum (Figure 3.21) showed a total of twenty one carbon signals; four 
aromatic carbons, three methines, seven methylenes, one methoxyl carbon and six 
quartenary carbons. The carbonyl quartenary carbon resonated at δ 174.7. The aromatic 
carbon (C-9, C-10, C-11 and C-12) appeared between δ 121.9 to δ 110.8 (Table 3.5). The 
assignments of the position of each carbon were also confirmed with 
1
H-
1
H COSY, DEPT, 
HSQC and HMBC. Complete spectral data for 
1
H and 
13
C NMR were listed in Table 3.5. 
Analysis of all spectra data obtained and comparison with the literature value
18
 led to the 
conclusion that compound E is 15-hydroxykopsinine. 
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Table 3.5: 
1H NMR [400 MHz, δH (J, Hz)] and 
13
C NMR [100 MHz, δC] of  
     15- hydroxykopsinine E in CDCl3 
Position    
1
H (J, Hz)     
13
C                           
2         66.9 
3    2.90 (m)    40.7 
    3.45 (m)       
4        
5    3.06 (m)    51.3 
    3.35 (dd, 15.9, 7.6 Hz)    
6    1.57 (m)    34.8 
    2.64 (m) 
7         58.1 
8         140.3 
9    7.23 (m)    121.9 
10    6.74 (t, 7.3 Hz)   120.1 
11    6.97 (t, 7.7Hz)    126.1 
12    6.63 (d, 7.7 Hz)   110.8  
13         148.9 
14    1.45 (m)    24.4   
    2.20 (m)       
15    3.65 (m)    71.7 
16    2.89 (m)    43.8 
17    1.40 (m)    31.9 
    2.66 (m)       
18    1.25 (m)    33.5 
    1.90 (m) 
19    1.24 (m)    27.5 
    1.89 (m)    
20         36.2 
21    3.66 (br s)    62.8  
22         174.7 
22-OCH3   3.75 (s)    52.2  
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Figure 3.20: 
1
H-NMR Spectrum of compound E 
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Figure 3.21: 
13
C-NMR Spectrum of compound E 
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Figure 3.22: HSQC Spectrum of compound E 
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Figure 3.23: HMBC Spectrum of compound E 
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3.6 COMPOUND F; singapurine  87 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound F was obtained as yellowish oil. The IR spectrum showed a broad band at 3358 
cm
-1
 representing a hydroxyl group. The 
1
H-NMR (Figure 3.24) showed the existence of an 
ethylidene group (δ 1.55, d, J = 6.8 Hz, H3-18; δ 5.80, q, J = 6.80 Hz, H-19), one 
deshielded methylene (δ 3.99, d, J = 8.2 Hz and δ 3.61, d, J = 8.2 Hz , H-5)  and one 
methoxyl signal at δ 3.82 (s) corresponding to 22-OCH3.  These signals are characteristic of 
an aspidodasycarpine type of alkaloids. 
1
H-NMR spectrum also showed the presence of 
four aromatic protons at δ 7.09 (d, 7.3 Hz, H-9), δ 6.85 (dt, 7.3, 1.1Hz, H-10), δ 7.19 (dt, 
7.8, 1.1 Hz, H-11) and δ 6.69 (d, 7.8 Hz, H-12). An N-methyl singlet appeared at δ 2.82. In 
addition a pair of deshielded doublet was apparent at δ 5.90 and δ 6.40 due to the 
resonances of the C-24 oxo methylene protons. 
  
The 
13
C-NMR spectrum (Figure 3.25) showed 23 signals corresponding to the 23 carbons; 
seven methines, six methylenes, one methoxyl, two methyls and seven quartenary     
carbons. (Table 3.6)  
 
 72 
 
The HMBC (Figure 3.28) spectrum of compound F showed the correlations of H-9/C-9, H-
10/C-10, H-11/C-11, H-12/C-12, C-12, C-2, C-7, C-8, C-13 and 23-N-CH3 which 
established the substructure of the indole alkaloid. The HMBC correlations of H-24a 
CH2OH with C-17 and H-24b CH2OH with C-3 were observed thus implying the 
connection between C-17 and C-24 through an ethereal linkage forming a new ring into the 
aspidodasycarpine skeleton. 
 
Thorough analysis of 
1
H-
1
H COSY (Figure 3.26) and C-H correlations from HSQC (Figure 
3.27) and HMBC (Figure 3.28) led us to propose the structure of alkaloid F as depicted in 
87. The proposed structure is based only on 
1
H-NMR and 
13
C-NMR (1D and 2D) due to its 
very minute quantity. 
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Table 3.6: 
1
H-NMR [400 MHz, δH (J, Hz)] and 
13
C NMR [100 MHz, δC] of compound F 
      in CDCl3 
 
Position                                   
1
H (J, Hz)                             
13
C                          
2         102.3 
3   4.69 (br s)       63.1 
4 
5   3.99 (d, 8.2 Hz)      74.4 
   3.61 (d, 8.2 Hz) 
6   3.74 (m)       27.2 
   1.83 (m) 
7           51.4 
8         136.7 
9   7.09 (d, 7.3 Hz)    122.7 
10   6.85 (dt, 7.3, 1.1 Hz)    121.7 
11   7.19 (dt, 7.8, 1.1 Hz)    128.9 
12   6.69 (d, 7.8 Hz)    111.6 
13         150.6 
14   2.98 (d, 15.5 Hz)      26.2 
   2.59 (d, 15.5 Hz) 
15   3.60 (m)       38.5 
16           56.2 
17   4.36 (m)       56.7 
   3.68 (m) 
18   1.55 (d, 6.8 Hz)      13.5 
19   5.80 (q, 6.8 Hz)    126.0 
20         129.8 
21   4.58 (d, 15 Hz)      64.1 
   5.12 (d, 15 Hz) 
22         170.7 
23-N-CH3  2.82 (s)     30.32 
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Continued.... 
 
Table 3.6: 
1H NMR [400 MHz, δH (J, Hz)] and 
13
C NMR [100 MHz, δC] of compound F 
          in CDCl3 
  
Position  
1
H (J, Hz)                              
13
C                          
24a-CH2OH  6.40 (d, 9.8 Hz)    72.12 
24b-CH2OH  5.90 (d, 9.8 Hz) 
22-OCH3  3.82 (s)     52.67 
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Figure 3.24: 
1
H-NMR Spectrum of compound F 
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Figure 3.25: 
13
C-NMR Spectrum of compound F 
 77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.26: COSY Spectrum of Compound F 
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Figure 3.27: HSQC Spectrum of Compound F 
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Figure 3.28: HMBC Spectrum of Compound F 
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3.7 COMPOUND G; N4-hydroxymethyl kopsinic acid 88 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound G was obtained as pale yellowish oil. The HREIMS showed the pseudo-
molecular ion peak at m/z 354.1341[M-H]
+
 corresponded to the molecular formula of 
C21H27N2O3.  The IR spectrum showed a broad band at 3391 cm
-1
 indicating the presence of 
hydroxyl group.
44
 
 
The 
1
H-NMR spectrum (Figure 3.29) indicated the presence of an unsubstituted indoline 
ring; (δ 7.07, m, 6.71, t, J = 8.0 Hz, 6.98, m and 6.65, d, J = 8.0 Hz). In addition deshielded 
signals due to the methylene proton at C-3 and C-5 appeared at δ 3.70 - 4.20. Normally the 
values of their resonances were in the region of δ 2.90 – 3.45 as obtained in compound E. 
This observation suggested that N-4 is an N4-hydroxymethyl. Moreover, H-21 which 
usually appeared at δ 3.66 (s),56  resonated as a singlet at δ 3.89 (13C-NMR; δ 74.9) in this 
compound. A downfield signal of a set of two doublets appeared at δ 5.56 (d, 10.7 Hz) and 
δ 5.06 (d, 10.7 Hz) which could be assigned to the methylene, H-22. 
 
11 10 
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The 
13
C NMR spectrum (Figure 3.30) indicated the presence of three sp
2
 quaternary 
carbons, four sp
2
 methines, nine sp
3
 methylenes, two sp
3
 methines and three sp
3
 quaternary 
carbons. More deshielded values for the 
13
C resonances of C-3 and C-5 were observed at    
δ 55.9 and δ 61.3 respectively. Usually the values are between δ 40 – 55.56,18 These 
observations confirmed that N-4 is indeed an N-CH2OH. The 
1
H-
1
H COSY spectrum 
(Figure 3.31) of compound G suggested the following fragments; C-3-C-14, C-5-C-6, C-
14-C-15, C-16-C-17 and C-18-C19. These correlations indicated that this alkaloid belong to 
the aspidofractinine skeleton. 
 
In addition the HMBC spectrum showed correlation between H-22 with C-3 and C-21, thus 
confirming the position of the hydroxymethyl on N4. The absolute stereochemistry is as 
indicated based on the absolute chemistry of the known kopsiloscine G, which is also 
isolated from this plant.
57
 Finally thorough analysis of compound G spectra, suggested that 
it is a new alkaloid named N4-hydroxymethyl kopsininic acid.
18
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Table 3.7: 
1H NMR [400 MHz, δH (J, Hz)] and 
13
C NMR [100 MHz, δC] of compound G 
          in CDCl3 
 
Position                                   
1
H (J, Hz)                             
13
C                          
2           66.3 
3   3.84 (m)       55.9 
   3.70 (m) 
4 
5   4.20 (m)       61.3 
   3.73 (m) 
6   3.23 (m)       31.1 
   1.54 (m) 
7           59.2  
8         137.1 
9   6.99 (m)     129.1 
10   6.70 (t, 7.8 Hz)    120.7 
11   6.96 (m)     120.8 
12   6.64 (d, 8.2 Hz)    113.9 
13         150.0 
14   2.26 (br d, 14.6 Hz)      16.7 
   1.83 (br d, 14.6 Hz) 
15   1.63 (m)       32.6 
   1.24 (m) 
16   2.72 (m)       44.1 
17   2.74 (m)       33.3 
   1.49 (m) 
18   1.67 (m)       35.0 
   1.28 (m) 
19   1.78 (m)       32.0 
   1.37 (m) 
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Continued.... 
Table 3.7: 
1H NMR [400 MHz, δH (J, Hz)] and 
13
C NMR [100 MHz, δC] of compound G 
          in CDCl3 
 
Position                                   
1
H (J, Hz)                             
13
C                          
 
20           32.9 
21   3.89 (s)       74.9 
22-CH2OH  5.56 (d, 10.7 Hz)    70.53 
   5.06 (d, 10.7 Hz)  
COOH         178.33 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 84 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.29: 
1
H-NMR Spectrum of compound G 
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Figure 3.29: 
1
H-NMR Spectrum of compound G 
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Figure 3.30: 
13
C-NMR Spectrum of compound G 
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Figure 3.31: COSY Spectrum of compound G 
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Figure 3.32 HSQC Spectrum of compound G 
Figure 3.33: HMBC Spectrum of compound G 
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BIOACTIVITY 
 
4.1   INTRODUCTION 
 
In the 1950s it was thought that the crisis of malaria had been solved.
58
 It gave the 
impression that the syndrome would be eradicated by the use of synthetic drugs such as  
chloroquine 116, primaquine  117 and  pyrimethamine  118 whilst the use of DDT and 
other insecticides could be relied upon to eradicate the mosquito host. Indeed, by 1956 the 
World Health Organization (WHO) had commenced a programmed of worldwide 
eradication of malaria. By 1966, this programmed was judged as being successful and 
several hundred million people were then living in former malaria regions without any risk 
of infection. Unfortunately, since that time, the situation has worsened dramatically because 
of the resistance of Plasmodium to clinically useful drugs and because of the resistance of 
vector mosquitoes to insecticides.
59
 
 
 
 
 
 
 
 
 
Many South-East Asian and South American countries now have increasing 
numbers of malaria cases per annum and the majority of these are caused by chloroquine-
11 10 
 90 
 
resistant strains of Plasmodium falciparum which causes malignant tertiary malaria. P. 
falciparum often produces fulminating infections in non-immune patients and such 
infections may prove fatal unless early. P. vivax produces milder attacks of benign tertian 
malaria and has a lower mortality rate in the untreated adults; relapses may well occur for at 
least 2 years after the primary infection. P. malariae, responsible for quartan malaria, may 
also give rise to relapses several years after the primary infection. The fourth species of 
Plasmodium which produces malaria in human is P. ovale and the infections are similar to 
those of P. vivax. 
 
Bites from female anopheline mosquitoes infected with Plasmodium sporozoites are 
responsible for transferring the disease to man (Scheme 4.1). During the symptom-free 
(pre-erythrocytic stages of the disease) the sporozoites rapidly disappear from the blood and 
inhabit the liver where they proliferate and sporulate. Merozoites released the liver to enter 
erythrocytes and start the blood cycle. Some of the parasites may infect tissue cells causing 
an exoerythrocytic stage but this does not occur with P. falciparum. Merozoites in the 
erythrocytes develop into trophozoites which reproduce asexually to form schizonts, from 
which many more merozoites burst out and infect more erythrocytes. The bursting of the 
erythrocytes is accompanied by feelings of intense coldness in patients. Some of the 
merozoites differentiate into male and female gametocytes which do not develop further 
unless blood is transferred to the female Anopheles mosquito whereupon the sexual phase 
of the life cycle of the malaria parasites takes place in the mosquito gut. 
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Scheme 4.1: Life Cycle of Plasmodium falciparum 
Adapted from Nature 415, 673-679, 2002 doi: 10.1038/415673a 
 
By 1960, resistance of Plasmodium to  chloroquine  116 was recognized and had 
been confirmed in Colombia and Venezuela as well as along Thailand and then Cambodian 
border. Resistance has continued to spread steadily and by 1977 it was confirmed in East 
Africa. In 1977, it was estimated that the worldwide incidence of malaria was 800 million 
per annum with 1.2 million deaths per annum.
60
 Malaria which is resistant to chloroquine 
116 has now been confirmed in more than 40 countries and it creates a huge threat to world 
health. In retrospect, it has been proposed that resistance to  chloroquine  116 was 
inevitable since the drug had been used in increasing quantities over 40-year period and by 
1985 it was estimated that more than 350 000 kg had been used to treat some 234 million 
doses.
61
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Although the problem of malaria is acknowledged to be a major one it remains 
difficult to obtain accurate figures for the number of cases. It has, for example, been 
pointed out that WHO estimate of 100 million cases per annum in 1986 should more 
realistically have been reported as 489 million clinical cases worldwide and that P. 
falciparum alone accounted for 234 million cases, of which 2.3 million proved to be 
deadly.
62
 Resistance to the more recently introduced  mefloquine  119 has also been 
reported, and resistance has been produced readily, in the laboratory, against        
artemisinin 120.
63
 
 
 
 
 
4.2 Assays for Antiplasmodial Activity 
 
The techniques accessible for the screening of drugs for antiplasmodial activity 
have been the subject of an extensive and comprehensive review.
64
 In 1912, techniques 
were developed for keeping P. falciparum and P. vivax alive for a few hours outside of the 
body and these techniques formed the basis of in vitro screening procedures for over half a 
century.  
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By 1920s and 1930s avian malarias including P. relictum in canaries, P. 
gallinaceum in chicks, P. cathemerium and P. lophurae in ducklings, were developed for 
primary screening of antiplasmodial activity. Inadequate use has been made of simian 
parasites in monkeys but there are obvious limitations of these methods for primary 
screening.  
 
In 1948, a major breakthrough in screening for antiplasmodial activity came through 
when the discovery of the rodent malaria parasite P. berghei at Kreyberg then Belgian 
Congo. This parasite, which readily infects laboratory mice and rats, has proved to be 
valuable for estimation of activity in chemotherapeutic research programmer in which more 
than 300 000 compounds have been screened.
64
  
 
4.3 Antiplasmodial Test Against Plasmodium falciparum Strains 
 
This procedure for evaluating compound effectiveness against Plasmodium falciparum 
(in vitro) utilize chloroquine  116 as a marker for inhibition of parasite growth.
65,66
  
Various alternative etiquettes exist, including the ones based on microscopic detection 
of Giemsa-stained slides, assays based on production of parasite lactate dehydrogenase, and 
the use of flow cytometry.
67
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4.4 Preparation of the Antiplasmodial Test 
68-75
 
  
Test involves five (5) major parts which will be discussed in the following 
subchapters. 
 
4.4.1 Malaria Culture Media 
 
RPMI 1640 medium containing 50 mg/liter hypoxanthine, 25mM HEPES, L-
glutamine (Catalog number 31800, Invitrogen), 10 g/ml gentamicin, 0.225% NaHCO3 and 
either 10% human serum or 0.5% Albumax I or II (purified lipid-rich bovine serum 
albumin, Invitrogen). Medium was adjusted to a pH about 7.3 to 7.4. 
 
4.4.2 Parasite Strain 
 
Some well-characterized strains (Table 4.1) are available, either from 
www.malaria.mr4.org (reagents available to registered users) or academic laboratories. One 
recommendation would be to test activity against a drug-sensitive line such as 3D7 (West 
Africa), D6 (Sierra Leone) or D10 (Papua New Guinea), as well as a drug-resistant line 
such as W2 or Dd2 (both from Indochina), 7G8 (Brazil), FCB (SE Asia) or K1 (Thailand).  
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Table 4.1: Standard Plasmodium falciparum Strains. 
Name Clone Origin Resistant to 
Multiplication 
Rate 
Dd2 Yes (from WR'82) Indochina CQ, QN, PYR, SDX 5-6 
W2 Yes (from 
Indochina-3) 
Indochina CQ, QN, PYR, SDX 5-6 
HB3 
Yes 
Honduras PYR 4 
3D7 
Yes (from NF54) 
Apparently West Africa - 4 
D6 Yes (from Sierra 
Leone-1) 
Sierra Leone - 4 
D10 Yes Papua New Guinea - 4 
CAMP No Malaysia PYR 4-5 
FCB No Apparently SE Asia CQ, QN, CYC 7-9 
7G8 Yes Brazil CQ, PYR, CYC 4-5 
K1 No Thailand CQ, PYR 4-5 
 
CQ, chloroquine; QN, quinine; PYR, pyrimethamine; SDX, sulfadoxine; CYC, cycloguanil. 
Multiplication rate refers to increase in total numbers of viable parasites per 48-hr generation. These rates and 
the drug phenotypes refer to data from the Fidock laboratory (Albert Einstein College of Medicine, NY) and 
may not be the same elsewhere. 
 
 
4.4.3 Preparation of Host Erythrocytes 
 
Human erythrocytes for parasite culture are prepared by drawing blood into 
heparin-treated tubes and washing several times in RPMI 1640 medium to separate the 
erythrocytes from the plasma and buffy coat.  
 
Separation can be achieved by centrifuging the blood at 500 x g for 5 minutes in a 
swing-out rotor. Leukocyte-free erythrocytes are typically stored at 50% hematocrit, i.e. 1 
volume of malaria culture media for 1 volume of packed erythrocytes, corresponding to 
approximately 5 x 10
9
 cells/ml. 
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4.4.4 Low Hypoxanthine Media 
 
Same as above except that the hypoxanthine concentration is reduced to 2.5 mg/liter. 
Serum (as opposed to Albumax) is important for culturing fresh isolates, and for 
maintaining properties of cytoadherence and gametocyte production (the latter is required 
for transmission back to mosquitoes).  
 
Some strains also prefer to propagate in serum. Batch-to-batch variation is 
nonetheless a problem, with occasional batches not supporting robust parasite growth. 
Accordingly, many laboratory lines have been adapted to propagate in the presence of 
Albumax, which typically gives more consistent growth between batches (variation was a 
problem in the past, but now appears to have been resolved). 
 
Albumax appears to reduce both the rate at which erythrocytes deteriorate in vitro 
and pH drift when cultures are exposed to ambient air, i.e. during tissue culture hood 
manipulations. 
 
4.4.5 Parasite Culture Conditions 
 
P. falciparum asexual blood stage parasites are propagated at 37°C in malaria 
culture media at 3-5% hematocrit in a reduced oxygen environment (e.g. a custom mixture 
of 5% O2, 5% CO2 and 90% N2). Lines can be conveniently cultured in 6-24 well tissue 
culture plates in a modular chamber (Billups-Rothenberg, Del Mar, CA, 
www.brincubator.com), with plates containing sterile water on the bottom to increase 
humidity and minimize desiccation.  
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These chambers can be suffused with the low O2 gas and maintained at 37°C in an 
incubator designed to minimize temperature fluctuations. Parasites can also be cultured in 
flasks that are individually gassed, or alternatively placed in flasks that permit gas exchange 
through the cap (in which case the incubator needs to be continuously infused with a low 
O2 gas mixture). Depending on the line, parasites typically propagate 3-8 fold every 48 
hours, thus care must be taken to avoid parasite cultures attaining too high a parasitemia, i.e. 
percentage of erythrocytes that are parasitized for healthy growth. Most lines grow 
optimally at 0.5 – 4% parasitemia. Parasites are most suitable for drug assays when they are 
2-5% parasitemia, and mostly ring stages with few or no gametocytes. 
 
Compounds can often be dissolved in 100% dimethyl sulfoxide (DMSO) and stored 
at –20°C. Particle size of insoluble compounds can be reduced by ball-milling or sonication. 
For the drug assays, serial drug dilutions are made in low hypoxanthine medium and added 
to 96-well culture plates at 100 ml per well. Drugs are added to columns 3-12 (test samples), 
with columns 1 and 2 reserved for wells with low hypoxanthine medium without compound. 
All drugs are typically tested in duplicate for each parasite line. Once completed, plates are 
placed into their own modular chamber, gassed and placed at 37°C. These plates should be 
set up no more than a few hours prior to addition of the parasites. 
 
IC50 values are determined by linear regression analyses on the linear segments of 
the curves (IC90 values can also be determined by curve-fitting and can provide a useful 
measure of variation between experiments). Assays are typically repeated on two or three 
separate occasions. Within each experiment, standard deviations are typically less than 10% 
of the mean. Differences in parasite stages of development can lead to up to two-fold shifts 
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in the IC50 values between experiments; however, these differences rarely affect the overall 
relationships between the parasite lines in terms of their differences in drug response. 
        
4.4.6 Antiplasmodial Activity Test Result of Crude Extract and Isolated Pure 
Compounds  
 
 
The bark of K. singapurensis was extracted with DCM. Hexane was then added to 
the dried extract and the mixture was stirred. The dissolved portion is separated from the 
undissolved portion of the crude extract. The dichloromethane crude extracts (DH & UDH) 
and isolated compounds of Kopsia singapurensis (bark) was tested against Plasmodium 
falciparum strains. The results were shown in Table 4.2 and Table 4.3. The DCM crude 
extract dissolved in hexane (DH) gave low value of IC50 compared to DCM crude extract 
undissolved in hexane (UDH). 
 
Table 4.2 Antiplasmodial activity from crude K. singapurensis 
 
 
 
Notes: 
 
 IC-50  < 25 µg/mL , to extract / fraction is considered as a potential anti-malarial 
 
 
 
 
 
SAMPLE IC50 (μg/mL) 
BARK – UDH 14.30 
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Compound methyl sinapate exhibited the most potent antiplasmodial activity with 
an IC50 of 0.11 followed by compound 15-hydroxykopsinine with an IC50 1.43. 
 
 
Table 4.3 Antiplasmodial activity from isolation of K. singapurensis 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMPOUND IC50 (μg/mL) 
 chloroquine Standard 0.0069 
methyl sinapate 82 0.1100 
trans-2,2`-dicarboxyazobenzene dioxide 84 - 
lonicerine 85 - 
15-hydroxykopsinine 86 1.4300 
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CONCLUSION 
 
 
 
The bark of Kopsia singapurensis has been studied for their chemical constituents. Their 
structures have been fully elucidated by conventional spectral methods such as; NMR (
1
H,
 
13
C and 2D), UV, IR, EIMS and HREIMS. 
 
The study on the bark of Kopsia singapurensis which belong to the family of Apocynaceae 
afforded 3 known indole alkaloids, namely leuconolam 83, lonicerine 85 and 15-
hydroxykopsinine 86 while methyl sinapate 82 and  trans-2,2`-dicarboxyazobenzene 
dioxide 84 are two new natural compounds in natural products. In addition two new 
alkaloids; singapurine 87 and N4-hydroxymethyl kopsinic acid 88 were obtained. 
 
This work has also shown that some of the constituents showed potent antiplasmodial 
activity against Plasmodium falciparum and compound 82 has interesting antiplasmodial 
activity. Perhaps compound 82 (IC50 = 0.1100 μg/mL) can be taken up as a lead compound 
for further structure activity studies on antiplasmodial activity.  
 
Other further works that can be done on chemicals of this plant is the study mechanism of 
the active compound 82(IC50 = 0.1100 μg/mL) and 86 (IC50 = 1.4300 μg/mL). 
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MATERIAL AND METHODS 
 
6.1 General Methods 
 
Spectra were recorded on the following instruments as follows: 
 
Infrared Spectra (IR) 
 
The infrared spectra were recorded on a Perkin Elmer FTIR (model 1600) 
spectrophotometer. CHCl3 is added to the sample and then the sample was applied evenly 
on the surface of the NaCl cell. After that the sample was dried using hair dryer. The NaCl 
cell was then placed to the sample holder and then data was collected. 
 
Liquid Chromatography Mass Spectrometer (LCMS) 
 
Mass spectra were recorded using Shimadzu Liquid Chromatography Mass Spectrometer 
Ion Trap Time of Fligth (LCMS-IT-TOF) using methanol as a solvent. 
 
Nuclear Magnetic Resonance (NMR) 
 
NMR spectra were obtained using JEOL JNM-FX100 (400 MHz). Deuterated chloroform 
(CDCl3) was used as NMR solvent. Chemical shifts were reported in ppm, and coupling 
constants were given in Hz. 
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6.2 Reagent 
 
6.2.1 Mayer’s Reagent (Potassium mercuric iodide) 
 It is a solution of 1.4g mercuric iodide in 60ml of distilled water mixed with a solution 
of 5.0g of potassium iodide in 10ml of distilled water. 
 The mixture was then made up to a 100ml solution. 
 A positive test is indicated by formation of a white precipitate when the aqueous layer 
(acidified) is treated with 2-3 drops of Mayer’s reagent. 
 
6.2.2 Dragendorff`s Reagent ( Potassium bismuth iodide ) 
Solution A:  Bismuth (III) nitrate (0.85g) in a mixture glacial acetic acid (10ml) 
and distilled water (40ml). 
Solution B:   Potassium iodide (8.0g) in distilled water (20ml). 
Stock solution:  A mixture of equal volumes of both Solution A and B. 
Spray Reagent:  The stock solution (20ml) was diluted in a mixture of acetic acid 
(20ml) and distilled water (60ml). 
Dragendorff`s Test:  A positive results yields formation of orange spots. 
 
 
6.3 Plant Material 
 
Kopsia singapurensis was collected by a team of phytochemist, Department of Chemistry, 
Faculty of Science, University of Malaya; with the herbarium series number KL 5334, 
located in Kluang, Johor Darul Takzim.  
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6.4 Extraction, isolation, purification and bioactivity of Kopsia singapurensis 
 
3.3 kg dried sample from the bark of Kopsia singapurensis was extracted and first defatted 
in hexane by soxhlet extractor for 17 hours. Then the extract was dried out on the rotary 
evaporator. After that, the extract was wetted with 10 % ammonia solution and left for 
overnight. They were then re-extracted successively with dichloromethane (CH2Cl2). After 
removal of the solvents, the crude extracts of hexane (58.0 g) and dichloromethane (50.0 g) 
was obtained for the bark. 
 
The dichloromethane (DCM) extract (bark) was partitioned with hexane for three days. The 
dissolved portion (DH) (9.0 g) was separated from the undissolved portion (UDH) (41.0g). 
The crude extract (30.0 g) from the plant material was subjected to column chromatography 
with by silica gel. Then, the column was eluted with solvent mixtures of increasing 
polarity, hexane, dichloromethane, and methanol. 45 fractions were obtained. Through 
1
H-
NMR analysis,  fraction 5 and 6 were pooled and subjected to column chromatography 
using solvent system with increasing polarity (Hexane:DCM to DCM:MeOH) which 
resulted compound A (Hexane:DCM; 1:9) and compound C (Hexane:DCM; 1:9). Whereas, 
about 220 tubes were generated from fraction 19 and resulted compound F 
(Dichloromethane:Methanol; 8.9:1.1).  Fraction 42 was also subjected to column 
chromatography to afford compound G (Dichloromethane:Methanol; 7.9:2.1). Meanwhile, 
compounds B (Hexane:Dichloromethane; 5:5), D (Dichloromethane:Methanol; 9.4:0.6) and 
E (Dichloromethane:Methanol; 9.4:0.6) was obtained using preparative thin layer 
chromatography method. 
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The fractions which given spots with the same Rf value were grouped into a series of 
fractions (observed by NMR and TLC). To purify the compound, each one of fractions 
were then treated individually by extensive column chromatography and preparative TLC 
 
The structural elucidation was carried out by spectroscopic methods (
1
H-NMR, 
13
C-NMR, 
COSY, DEPT, HMBC, HMQC, IR and UV). Then, the crude extract and the isolated 
compounds were subjected to screening for antiplasmodial activity. 
 
The flow chart of the extraction, isolation, purification and bioactivity process is shown in 
Scheme 6.4. 
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Kopsia singapurensis (Bark 3.3 kg) 
 
                      
      hexane 
 
 
   
Crude hexane            Residue 
                              (58.0g)                       
      Moistened 25% ammonia 
           Dichloromethane (DCM) 
 
                DCM crude (50.0g) 
 
                                                                                             hexane 
       
 
  Dissolved portion (DH)             Undissolved portion (UDH) 
       (9.0g)                                                             (41.0g)                            
 Test for antiplasmodial activity              Test for antiplasmodial activity 
                                                                                                                     
                                                                                                                 CC (45 Fractions) 
 
 
            F17-18                            F42-125              F19-128                      F5-6 
  
     PTLC                                                                       CC                                                  
                   CC  CC  
    
            CC         PTLC 
 
  
 
 
     
             
                                                                                                                                                                           
 
 
 
 
 
        Test for antiplasmodial activity 
 
 
 
 References: 
Compound B 
  (0.0020 g) 
Hex: DCM 
     (5: 5) 
Compound D 
  (0.0065 g) 
DCM: MeOH 
     (9.4: 0.6) 
 
Compound E 
  (0.0183 g) 
DCM: MeOH 
    (9.4: 0.6) 
Compound F 
   (0.0044 g) 
DCM: MeOH 
     (8.9: 1.1) 
 
 
 
Compound G 
   (0.0073 g) 
DCM: MeOH 
     (7.9: 2.1) 
Compound A 
  (0.0022 g) 
Hex: DCM 
     (1: 9) 
Compound C 
  (0.0040 g) 
Hex: DCM 
     (1: 9) 
Scheme 6.4: Extraction, isolation and purification of compounds Kopsia singapurensis (bark) 
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